Stock Fundamentals

Company Information

Company Name
Veru Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US92536C1036
CIK: 0000863894
CUSIP: 976817106
Currency: USD
Full Time Employees: 20
Phone: 305 509 6897
Fiscal Year End: September
IPO Date: Jul 19, 1990
Description:

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

Address:

2916 North Miami Avenue, Miami, FL, United States, 33127

Directors & Officers

Name Title Year Born
Dr. Mitchell S. Steiner F.A.C.S., M.D. Chairman, President & CEO 1961
Dr. Harry D. Fisch F.A.C.S., M.D. Vice Chairman & Chief Corporate Officer 1959
Dr. K. Gary Barnette Ph.D. Chief Scientific Officer 1968
Ms. Michele Greco CPA CFO & Chief Administrative Officer 1959
Mr. Samuel Fisch Executive Director of Investor Relations & Corporate Communications NA
Mr. Philip R. Greenberg J.D. Executive VP, General Counsel & Secretary NA
Mr. Kevin J. Gilbert CPA, J.D. Executive Vice President of Corporate Development NA
Mr. Martin Tayler Executive Vice President of FC2 Global Operations 1969
Dr. Domingo Rodriguez M.D. Executive Vice President of Global Clinical Operations 1962
Dr. Gary Bird Ph.D. Executive Vice President of Quality & Regulatory Affairs NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 18, 2025 Michael L Rankowitz N/A Purchase 9.53K $5.50 $52.40K
May 24, 2024 K Gary Barnette N/A Purchase 500.00 $13.40 $6.70K
May 24, 2024 Mitchell Shuster Steiner N/A Sale 6.34K $12.30 $77.95K
May 22, 2024 Mitchell Shuster Steiner N/A Sale 650.00 $13.90 $9.04K
May 17, 2024 Mitchell Shuster Steiner N/A Sale 2.81K $13.20 $37.04K
May 15, 2024 Harry Fisch N/A Purchase 671.00 $14.90 $10.00K
May 15, 2024 Mitchell Shuster Steiner N/A Sale 8.40K $15.00 $126.03K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Alyeska Investment Group, L.P. 1.00M Mar 31, 2026 6.23% $0.01 0.00%
Vanguard Group Inc 634.04K Dec 31, 2025 3.95% $0.00 -1.04%
Vanguard Capital Management, LLC 539.38K Mar 31, 2026 3.36% $0.00 0.00%
Oppenheimer & Co Inc 196.30K Mar 31, 2026 1.22% $0.01 -0.80%
GSA Capital Partners LLP 189.70K Mar 31, 2026 1.18% $0.03 -3.06%
Geode Capital Management, LLC 184.62K Mar 31, 2026 1.15% $0.00 18.83%
Summit Financial LLC 151.78K Mar 31, 2026 0.95% $0.00 -0.47%
Millennium Management LLC 150.40K Mar 31, 2026 0.94% $0.00 -19.96%
Ikarian Capital, LLC 133.52K Mar 31, 2026 0.83% $0.02 0.00%
BlackRock Inc 114.17K Mar 31, 2026 0.71% $0.00 -0.16%
Vanguard Fiduciary Trust Co 80.65K Mar 31, 2026 0.50% $0.00 0.00%
RSM US WEALTH MANAGEMENT LLC 75.26K Mar 31, 2026 0.47% $0.00 -0.09%
Goss Wealth Management LLC 70.53K Dec 31, 2025 0.44% $0.00 388.74%
Renaissance Technologies Corp 69.25K Mar 31, 2026 0.43% $0.00 0.00%
State Street Corp 55.00K Mar 31, 2026 0.34% $0.00 0.00%
Blair William & Co 48.00K Mar 31, 2026 0.30% $0.00 0.00%
Citadel Advisors Llc 44.48K Mar 31, 2026 0.28% $0.00 -60.48%
ADAR1 Capital Management LLC 35.00K Mar 31, 2026 0.22% $0.00 0.00%
Northern Trust Corp 33.59K Mar 31, 2026 0.21% $0.00 0.00%
BOOTHBAY FUND MANAGEMENT, LLC 31.52K Mar 31, 2026 0.20% $0.00 0.00%

Shares Statistics

Shares Outstanding: 16.05M
Shares Float: 13.48M
% Insiders: 978.20%
% Institutions: 2,392.20%
Short % Float: 3.90%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 380.64K 2.37% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 158.74K 0.99% ▲ 0.00% Apr 30, 2026
3 Fidelity Extended Market Index 99.85K 0.62% ▼ 0.36% Apr 30, 2026
4 Extended Equity Market Fund E 25.70K 0.16% ▲ 0.00% Dec 31, 2025
5 Blackrock Extended Mkt Fund CF 25.70K 0.16% ▲ 0.00% Apr 30, 2026
6 Extended Equity Market Fund B 25.70K 0.16% ▲ 0.00% Dec 31, 2025
7 Fidelity Total Market Index 23.04K 0.14% ▲ 0.00% Apr 30, 2026
8 BlackRock Extended Equity Market Fund K 21.88K 0.14% ▼ 0.73% Mar 31, 2026
9 Northern Trust Extended Eq Market Idx 21.52K 0.13% ▲ 59.53% Mar 31, 2026
10 NT Ext Equity Mkt Index Fund - Lending 21.52K 0.13% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $20.46M
Trailing P/E: 0.00
Forward P/E: 117.65

Financial Highlights

Market Cap: $48.15M
EBITDA: $-28.02M
PEG Ratio: $3.60
Book Value: $2.31
Earnings/Share: $-0.80
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -46.42%
ROE (TTM): -51.74%
Revenue (TTM): $16.89M
Revenue/Share (TTM): $1.15
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 18.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-09-30 2.43x 0.04x 0.39x N/A -0.02x
2024-09-30 2.97x 0.34x 0.47x -60.77x -0.30x
2023-09-30 1.29x 0.55x 0.61x -38.64x -0.12x
2022-09-30 2.69x 0.14x 0.39x -19.05x -0.14x
2021-09-30 9.62x 0.09x 0.15x 2.66x 1.35x
2020-09-30 1.83x 0.44x 0.42x -3.19x -0.92x
2019-09-30 1.20x 0.26x 0.40x -1.37x -1.39x
2018-09-30 0.83x 0.38x 0.39x -7.07x -0.55x
2017-09-30 1.88x 0.00x 0.12x -4.16x 0.00x
2016-09-30 5.47x 0.00x 0.12x 0.91x 0.00x
2015-09-30 5.11x 0.00x 0.12x 52.07x 0.00x
2014-09-30 3.87x 0.00x 0.11x 77.60x 0.00x
2013-09-30 4.96x 1.84x 0.11x 227.83x 5.59x
2012-09-30 2.87x 0.00x 0.20x 36.94x 0.00x
2011-09-30 4.25x 0.00x 0.14x 26.44x 0.00x
2010-09-30 6.08x 8.20x 0.12x 1.09x 28.21x
2009-09-30 2.71x 0.24x 0.30x 1.98x 0.57x
2008-09-30 4.05x 0.01x 0.30x 1.52x 0.01x
2007-09-30 3.96x 0.00x 0.33x 11.69x 0.00x
2006-09-30 4.21x 0.00x 0.36x N/A 0.00x
2005-09-30 4.08x 0.00x 0.42x N/A 0.00x
2004-09-30 2.76x 0.26x 0.59x N/A 24.79x
2003-09-30 1.27x 4.62x 0.90x N/A 10.83x
2002-09-30 1.86x 3.66x 0.89x N/A -1.39x
2001-09-30 1.37x 39.23x 0.99x N/A 6.39x
2000-09-30 0.58x -3.77x 1.17x N/A -3.21x
1999-09-30 1.17x 1.16x 0.74x N/A -1.15x
1998-09-30 1.46x 0.21x 0.61x N/A -0.23x
1997-09-30 1.60x 0.25x 0.57x N/A -0.19x
1996-09-30 1.52x 0.02x 0.45x N/A -0.02x
1995-09-30 1.52x 0.01x 0.45x N/A -0.01x
1994-09-30 2.86x 0.01x 0.32x N/A -0.05x
1993-09-30 1.00x 0.02x 0.57x N/A -0.04x
1992-09-30 1.29x 0.24x 0.46x N/A -1.18x
1991-09-30 1.45x 0.02x 0.43x N/A -0.06x
1990-09-30 2.88x 0.10x 0.33x N/A 0.75x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about VERU.US!